David A Cameron Selected Research

David A Cameron Research Topics

Disease

68	Breast Neoplasms (Breast Cancer) 10/2022 - 06/2002
28	Neoplasms (Cancer) 01/2022 - 05/2005
7	Neoplasm Metastasis (Metastasis) 11/2021 - 05/2005
6	Cardiotoxicity 01/2020 - 09/2008
5	Disease Progression 01/2022 - 09/2008
4	Ovarian Neoplasms (Ovarian Cancer) 09/2007 - 04/2006
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2016 - 07/2014
2	Inflammatory Breast Neoplasms 06/2009 - 09/2008
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Leukopenia 11/2016
1	Neutropenia 11/2016
1	Brain Neoplasms (Brain Tumor) 05/2011
1	Injection Site Reaction 01/2011
1	Primary Ovarian Insufficiency 10/2010
1	Muscular Dystrophies (Muscular Dystrophy) 07/2010
1	Retinal Degeneration 09/2009
1	Febrile Neutropenia 02/2008

Drug/Important Bio-Agent (IBA)

16	Hormones (Hormone)IBA 10/2022 - 12/2006
12	Estrogen ReceptorsIBA 01/2019 - 12/2006
11	Trastuzumab (Herceptin)FDA Link 01/2022 - 09/2008
10	Letrozole (Femara)FDA LinkGeneric 10/2022 - 09/2005
9	human ERBB2 proteinIBA 10/2022 - 10/2007
9	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2007
9	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2015 - 05/2005
7	AnthracyclinesIBA 12/2016 - 09/2008
7	Docetaxel (Taxotere)FDA Link 06/2015 - 05/2005
7	Tamoxifen FDA LinkGeneric 01/2010 - 09/2005
6	Estrogens (Estrogen)FDA Link 02/2022 - 12/2006
5	Fluorouracil (Carac)FDA LinkGeneric 06/2015 - 02/2008
5	Aromatase InhibitorsIBA 02/2009 - 12/2006
4	Pharmaceutical PreparationsIBA 01/2022 - 02/2008
4	Epirubicin (Ellence)FDA LinkGeneric 06/2015 - 11/2005
4	ParaffinIBA 04/2013 - 03/2007
3	ribociclibIBA 10/2022 - 11/2016
3	Lapatinib (GW572016)FDA Link 01/2022 - 09/2008
3	Biomarkers (Surrogate Marker)IBA 11/2021 - 01/2010
3	pertuzumabIBA 08/2013 - 01/2007
3	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2010 - 05/2005
3	Anastrozole (Arimidex)FDA LinkGeneric 02/2009 - 05/2007
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2009 - 01/2004
2	Biological ProductsIBA 01/2022 - 01/2012
2	Capecitabine (Xeloda)FDA Link 10/2021 - 09/2008
2	Diphosphonates (Bisphosphonates)IBA 01/2016 - 01/2003
2	Methotrexate (Mexate)FDA LinkGeneric 05/2015 - 03/2010
2	Formaldehyde (Formol)FDA Link 04/2013 - 08/2012
2	taxaneIBA 04/2013 - 06/2011
2	Protein Isoforms (Isoforms)IBA 08/2012 - 04/2006
2	Taxoids (Taxanes)IBA 06/2011 - 09/2008
2	VaccinesIBA 01/2011 - 06/2002
2	Retinaldehyde (Retinal)IBA 07/2010 - 05/2005
2	ErbB Receptors (EGF Receptor)IBA 03/2010 - 09/2008
2	OpsinsIBA 09/2009 - 08/2006
2	exemestane (Aromasin)FDA Link 02/2009 - 10/2008
2	Aromatase (CYP19)IBA 10/2008 - 09/2007
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 02/2008 - 02/2008
2	Estrogen Receptor alphaIBA 11/2007 - 12/2006
2	Indicators and Reagents (Reagents)IBA 09/2007 - 03/2007
2	Messenger RNA (mRNA)IBA 09/2007 - 03/2007
1	RoscovitineIBA 02/2022
1	trastuzumab deruxtecanIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 11/2021
1	Vinorelbine (Navelbine)FDA LinkGeneric 10/2021
1	Gemcitabine FDA Link 10/2021
1	niraparibIBA 10/2021
1	eribulin FDA Link 10/2021
1	tetrachloroisophthalonitrile (Bravo)IBA 10/2021
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 11/2016
1	Phenobarbital (Luminal)FDA Link 01/2016
1	Zoledronic Acid (Zometa)FDA Link 01/2016
1	Bevacizumab (Avastin)FDA Link 06/2015
1	Ado-Trastuzumab EmtansineIBA 08/2013
1	Cytotoxins (Cytolysins)IBA 08/2013
1	Cell Surface ReceptorsIBA 08/2013
1	Tissue Inhibitor of Metalloproteinase-1IBA 04/2013
1	tyrosine receptor (receptor, tyrosine)IBA 07/2012
1	Phosphotransferases (Kinase)IBA 07/2012
1	keyhole-limpet hemocyanin (keyhole limpet hemocyanin)IBA 01/2011
1	thiamine triphosphorate (TTP)IBA 01/2011
1	sialyl-Tn antigen-keyhole-limpet hemocyanin conjugateIBA 01/2011
1	protein O-mannose beta-1,2-N-acetylglucosaminyltransferaseIBA 07/2010
1	Mannose (D-Mannose)IBA 07/2010
1	N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase (N-acetylglucosaminyltransferase)IBA 07/2010
1	Large Neutral Amino Acid-Transporter 1IBA 01/2010
1	Vitamin A (Retinol)FDA LinkGeneric 09/2009
1	Rhodopsin (Visual Purple)IBA 09/2009
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2008
1	Estrogen Receptor Modulators (Antiestrogen)IBA 10/2008
1	Monoclonal AntibodiesIBA 09/2008
1	Estrone FDA Link 04/2008
1	Estradiol (Delestrogen)FDA LinkGeneric 04/2008

Therapy/Procedure

30	Therapeutics 10/2022 - 05/2005
24	Drug Therapy (Chemotherapy) 01/2022 - 05/2005
8	Adjuvant Chemotherapy 10/2021 - 10/2007
4	Neoadjuvant Therapy 01/2019 - 06/2011
4	Radiotherapy 03/2015 - 12/2009
1	Treatment Delay 12/2016
1	Segmental Mastectomy (Lumpectomy) 03/2015
1	Chemoprevention 03/2014
1	Ligation 08/2012